Stonepine Capital Management as of Dec. 31, 2017
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 27 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Viveve Med | 11.5 | $19M | 3.8M | 4.97 | |
| BioSpecifics Technologies | 10.0 | $17M | 386k | 43.33 | |
| Apollo Endosurgery | 8.6 | $14M | 2.6M | 5.60 | |
| Vanda Pharmaceuticals (VNDA) | 8.1 | $14M | 885k | 15.20 | |
| Enanta Pharmaceuticals (ENTA) | 7.7 | $13M | 218k | 58.68 | |
| BioDelivery Sciences International | 6.5 | $11M | 3.6M | 2.95 | |
| Recro Pharma | 5.8 | $9.7M | 1.1M | 9.25 | |
| Cumberland Pharmaceuticals (CPIX) | 5.8 | $9.6M | 1.3M | 7.36 | |
| Veracyte (VCYT) | 4.8 | $8.1M | 1.2M | 6.53 | |
| Ophthotech | 4.4 | $7.3M | 2.4M | 3.12 | |
| Caredx (CDNA) | 4.0 | $6.8M | 920k | 7.34 | |
| Noveliontherapeuti.. | 3.2 | $5.3M | 1.7M | 3.12 | |
| Cardiome Pharma | 3.0 | $5.0M | 3.2M | 1.55 | |
| Cti Biopharma | 3.0 | $4.9M | 1.8M | 2.68 | |
| Alimera Sciences | 2.8 | $4.7M | 3.6M | 1.33 | |
| Cancer Genetics | 2.0 | $3.3M | 1.8M | 1.85 | |
| Medicrea International | 1.5 | $2.6M | 714k | 3.60 | |
| Strongbridge Bioph shs usd | 1.5 | $2.5M | 344k | 7.25 | |
| Steadymed | 1.4 | $2.3M | 618k | 3.70 | |
| Eiger Biopharmaceuticals | 1.2 | $2.1M | 150k | 13.95 | |
| Neos Therapeutics | 0.9 | $1.4M | 140k | 10.20 | |
| Acer Therapeutics | 0.8 | $1.4M | 100k | 13.85 | |
| Vical | 0.7 | $1.2M | 676k | 1.83 | |
| Verastem | 0.4 | $691k | 225k | 3.07 | |
| Aquinox Pharmaceuticals | 0.3 | $476k | 41k | 11.75 | |
| Adma Biologics (ADMA) | 0.1 | $217k | 68k | 3.21 | |
| Amarin Corporation | 0.0 | $70k | 18k | 3.99 |
